Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 12 | 2022 | 142 | 4.340 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2019 | 207 | 3.000 |
Why?
|
| Muscarinic Antagonists | 4 | 2019 | 54 | 2.280 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 4 | 2019 | 27 | 2.270 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2017 | 40 | 1.570 |
Why?
|
| Cognitive Dysfunction | 3 | 2018 | 176 | 1.390 |
Why?
|
| Benzyl Alcohols | 2 | 2019 | 4 | 1.240 |
Why?
|
| Chlorobenzenes | 2 | 2019 | 8 | 1.230 |
Why?
|
| Androstadienes | 2 | 2019 | 41 | 1.220 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 565 | 1.000 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2022 | 33 | 0.970 |
Why?
|
| Cognition Disorders | 4 | 2015 | 342 | 0.960 |
Why?
|
| Drug Combinations | 2 | 2019 | 304 | 0.760 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2021 | 28 | 0.750 |
Why?
|
| Down Syndrome | 3 | 2017 | 120 | 0.720 |
Why?
|
| Carbamates | 1 | 2019 | 41 | 0.690 |
Why?
|
| Polysomnography | 4 | 2021 | 92 | 0.680 |
Why?
|
| Benzamides | 1 | 2019 | 156 | 0.640 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 94 | 0.630 |
Why?
|
| Blood Proteins | 1 | 2018 | 94 | 0.620 |
Why?
|
| Quinuclidines | 1 | 2016 | 10 | 0.570 |
Why?
|
| Neuropsychological Tests | 6 | 2022 | 517 | 0.570 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.560 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 43 | 0.550 |
Why?
|
| Proteomics | 1 | 2018 | 246 | 0.540 |
Why?
|
| Asthma | 1 | 2019 | 345 | 0.510 |
Why?
|
| Atherosclerosis | 1 | 2017 | 204 | 0.510 |
Why?
|
| Tropanes | 1 | 2015 | 3 | 0.500 |
Why?
|
| Glucocorticoids | 1 | 2016 | 222 | 0.500 |
Why?
|
| Ethanolamines | 1 | 2015 | 33 | 0.500 |
Why?
|
| Sarcoidosis | 1 | 2015 | 77 | 0.490 |
Why?
|
| Postal Service | 1 | 2014 | 19 | 0.480 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 83 | 0.480 |
Why?
|
| Quality of Life | 3 | 2021 | 1515 | 0.460 |
Why?
|
| Dementia | 1 | 2015 | 158 | 0.450 |
Why?
|
| Humans | 26 | 2022 | 68618 | 0.450 |
Why?
|
| Parasitic Diseases | 1 | 2013 | 9 | 0.450 |
Why?
|
| Pleura | 1 | 2013 | 25 | 0.440 |
Why?
|
| Pleural Diseases | 1 | 2013 | 20 | 0.440 |
Why?
|
| Administration, Inhalation | 3 | 2017 | 187 | 0.400 |
Why?
|
| Lung | 1 | 2016 | 849 | 0.400 |
Why?
|
| Patient Compliance | 1 | 2014 | 402 | 0.400 |
Why?
|
| Mass Screening | 2 | 2015 | 843 | 0.400 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2011 | 110 | 0.350 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 940 | 0.340 |
Why?
|
| Comorbidity | 3 | 2019 | 1426 | 0.310 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 446 | 0.280 |
Why?
|
| Cohort Studies | 3 | 2018 | 2358 | 0.270 |
Why?
|
| Middle Aged | 5 | 2019 | 21147 | 0.200 |
Why?
|
| Treatment Outcome | 3 | 2019 | 7029 | 0.190 |
Why?
|
| Female | 8 | 2019 | 38074 | 0.190 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 153 | 0.180 |
Why?
|
| Adenoidectomy | 2 | 2017 | 51 | 0.180 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 87 | 0.170 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 34 | 0.170 |
Why?
|
| Tonsillectomy | 2 | 2017 | 69 | 0.170 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 329 | 0.160 |
Why?
|
| Ceruloplasmin | 1 | 2018 | 8 | 0.160 |
Why?
|
| Angiopoietin-1 | 1 | 2018 | 12 | 0.160 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 567 | 0.160 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 50 | 0.160 |
Why?
|
| Cathepsin B | 1 | 2018 | 33 | 0.160 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 58 | 0.160 |
Why?
|
| Adiponectin | 1 | 2018 | 52 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 88 | 0.150 |
Why?
|
| Aged | 4 | 2019 | 14862 | 0.150 |
Why?
|
| Health Surveys | 1 | 2019 | 489 | 0.150 |
Why?
|
| Tachycardia, Sinus | 1 | 2017 | 4 | 0.150 |
Why?
|
| Reference Values | 1 | 2018 | 579 | 0.140 |
Why?
|
| Morbidity | 1 | 2017 | 130 | 0.140 |
Why?
|
| Global Health | 1 | 2017 | 136 | 0.140 |
Why?
|
| Risk Factors | 3 | 2015 | 5731 | 0.140 |
Why?
|
| Weight Gain | 1 | 2017 | 135 | 0.140 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 71 | 0.140 |
Why?
|
| Parasomnias | 1 | 2016 | 2 | 0.140 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2016 | 5 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2019 | 335 | 0.140 |
Why?
|
| Male | 7 | 2019 | 37321 | 0.130 |
Why?
|
| Space Perception | 1 | 2015 | 44 | 0.130 |
Why?
|
| Menstrual Cycle | 1 | 2015 | 64 | 0.130 |
Why?
|
| Sleep Apnea, Central | 1 | 2015 | 6 | 0.130 |
Why?
|
| Postmenopause | 1 | 2015 | 93 | 0.130 |
Why?
|
| Hypoventilation | 1 | 2015 | 8 | 0.130 |
Why?
|
| Facial Bones | 1 | 2015 | 10 | 0.130 |
Why?
|
| Insulin | 1 | 2018 | 619 | 0.120 |
Why?
|
| Formoterol Fumarate | 1 | 2015 | 25 | 0.120 |
Why?
|
| Prevalence | 1 | 2019 | 1619 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2015 | 106 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 253 | 0.120 |
Why?
|
| Estradiol | 1 | 2015 | 176 | 0.120 |
Why?
|
| Survival Rate | 1 | 2017 | 1056 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2017 | 7277 | 0.120 |
Why?
|
| Pharynx | 1 | 2015 | 89 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2015 | 219 | 0.120 |
Why?
|
| Drug Interactions | 1 | 2015 | 289 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 786 | 0.120 |
Why?
|
| Sleep | 1 | 2016 | 263 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 513 | 0.110 |
Why?
|
| Adult | 4 | 2015 | 21403 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2016 | 506 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 649 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2279 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 212 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 848 | 0.110 |
Why?
|
| Self Report | 1 | 2014 | 371 | 0.100 |
Why?
|
| Research Design | 1 | 2016 | 729 | 0.100 |
Why?
|
| Curriculum | 1 | 2016 | 575 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2015 | 621 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2800 | 0.100 |
Why?
|
| Logistic Models | 1 | 2015 | 1420 | 0.090 |
Why?
|
| Animals | 3 | 2016 | 20881 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 1076 | 0.070 |
Why?
|
| United States | 1 | 2019 | 7367 | 0.070 |
Why?
|
| Brain | 1 | 2015 | 2176 | 0.060 |
Why?
|
| Ventricular Fibrillation | 1 | 2022 | 85 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2017 | 3187 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 239 | 0.040 |
Why?
|
| Palate | 1 | 2017 | 14 | 0.040 |
Why?
|
| Tongue | 1 | 2017 | 20 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1603 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2017 | 31 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 36 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2017 | 164 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 238 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.030 |
Why?
|
| Child | 2 | 2017 | 6405 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 3259 | 0.030 |
Why?
|
| Rotation | 1 | 2015 | 58 | 0.030 |
Why?
|
| Imagination | 1 | 2015 | 38 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 5717 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 170 | 0.030 |
Why?
|
| South Carolina | 1 | 2021 | 2752 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 8912 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 867 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 403 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 532 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 2891 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2012 | 122 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.020 |
Why?
|